(Q45225362)
Statements
Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation (English)
Hongli Dong
Eun Jung Kim
Lewis Weintraub